TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24816936

Group type: EXPERIMENTAL
Intervention: Low-dose unenhanced ungated chest CT for AVC measurement
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Low-dose unenhanced ungated chest CT for MC measurement
Number of subjects: 578
Study: 22116011

Group type: EXPERIMENTAL
Intervention: Financial Incentive Coercion Assessment (FICA) questionnaire
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: FICA results
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Initial assessment of responses on the FICA
Number of subjects: 266
Study: 20060578

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent
Number of subjects: 1800
Study: 17604556

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (N=4)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Sham acupuncture (N=3)
Number of subjects: 7
Study: 16110738

Group type: EXPERIMENTAL
Intervention: Participants in the GISSA intervention study
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Non-participants who refused, did not respond, or withdrew
Number of subjects: 1269
Study: 12087908

Group type: EXPERIMENTAL
Intervention: Intensive treatment program (synchronous plasmapheresis, large-dose methotrexate and methylprednisolone)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Pulse therapy with methylprednisolone (3 g) and methotrexate (200 mg)
Number of subjects: 45
Study: 10195618

Group type: EXPERIMENTAL
Intervention: Trypsin-modified inactivated poliovirus vaccine (TryIPV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced potency inactivated poliovirus vaccine (E-IPV)
Number of subjects: 0
Study: 7780243

Group type: EXPERIMENTAL
Intervention: High cholesterol formula (30 mg/dl cholesterol)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Breast milk (mean cholesterol content 15.3 mg/dl)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard preterm formula (cholesterol content 5.5 mg/dl)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Low cholesterol formula
Number of subjects: 44
Study: 2141104

Group type: EXPERIMENTAL
Intervention: Salbutamol, 2.5 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Ipratropium, 0.250 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Salbutamol + Ipratropium
Number of subjects: 31

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 31
Study: 637066

Group type: EXPERIMENTAL
Intervention: Imagery
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Rote repetition
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study: 30945991

Group type: EXPERIMENTAL
Intervention: Weight training combined with pelvic floor muscle training (moderate intensity, twice a week for 12 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Pelvic floor muscle training alone
Number of subjects: 26
Study: 27417272

Group type: EXPERIMENTAL
Intervention: Behavioral nutrition intervention
Number of subjects: 136
Study: 25891042

Group type: EXPERIMENTAL
Intervention: Real condition (food addiction is real)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Myth condition (food addiction is a myth)
Number of subjects: 60
Study: 23263396

Group type: EXPERIMENTAL
Intervention: Aquacel Ag dressing
Number of subjects: 92

Group type: COMPARATOR
Intervention: Iodoform dressing
Number of subjects: 92
Study: 21368086

Group type: COMPARATOR
Intervention: Alcoholics (during rest)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcoholics (during task)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls (during rest)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls (during task)
Number of subjects: 0
Study: 19186028

Group type: EXPERIMENTAL
Intervention: Hypnosis session with specific suggestions to increase salivation, recorded on a CD, listened to twice a day for one month
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hypnosis session
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hypnosis CD listening frequency
Number of subjects: 12
Study: 16255784

Group type: EXPERIMENTAL
Intervention: Biomass fuel use (wood)
Number of subjects: 369

Group type: COMPARATOR
Intervention: LPG (Liquefied Petroleum Gas) use
Number of subjects: 369
Study: 12048134

Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg/day for 8 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg/day for up to 104 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 25
Study: 10368193

Group type: EXPERIMENTAL
Intervention: Prelubricated, hydrophilic PVC catheter
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-hydrophilic PVC catheter
Number of subjects: 32
Study: 7744936

Group type: EXPERIMENTAL
Intervention: Thorough saline lavage of the femoral canal
Number of subjects: 24

Group type: COMPARATOR
Intervention: Minimal saline lavage of the femoral canal
Number of subjects: 24
Study: 2304406

Group type: EXPERIMENTAL
Intervention: Light weight belt (LB)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Heavy weight belt (HB)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No belt (NB)
Number of subjects: 6
Study: 6118757

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Indoramin
Number of subjects: 20
Study: 31908865

Group type: EXPERIMENTAL
Intervention: Outreach training and the PACK guide
Number of subjects: 6666

Group type: COMPARATOR
Intervention: Control group (only the PACK guide)
Number of subjects: 6666
Study: 29130440

Group type: EXPERIMENTAL
Intervention: Theory-based brief intervention involving emotionally evocative photographs and discussions with a healthcare provider.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Theory-based brief intervention.
Number of subjects: 87
Study: 25688120

Group type: EXPERIMENTAL
Intervention: Dose-dense temozolomide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-dose temozolomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Progressed patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonprogressors
Number of subjects: 0
Study: 23603021

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the right angular gyrus (AG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS (identical electrode set-up without stimulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no electrodes attached)
Number of subjects: 0
Study: 21272986

Group type: EXPERIMENTAL
Intervention: Glidescope(®)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 45
Study: 19876936

Group type: EXPERIMENTAL
Intervention: Nevirapine extended release tablets with varying polymer contents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fastest ER formulation (used as reference for UIR)
Number of subjects: 0
Study: 17074337

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg twice daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (150 mg for 5 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (healthy normal cycled women)
Number of subjects: 40
Study: 15597184

Group type: EXPERIMENTAL
Intervention: Stream of three items belonging to the same category (e.g., letters or digits)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insertion of an item from a different category in the target string
Number of subjects: 0

Group type: COMPARATOR
Intervention: Theoretical accounts of attentional blink
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporary loss of control over the prevailing attentional set
Number of subjects: 0
Study: 12188409

Group type: EXPERIMENTAL
Intervention: Sitting pelvic tilt exercise for 8 weeks during the third trimester
Number of subjects: 67
Study: 10432138

Group type: EXPERIMENTAL
Intervention: Misoprostol (600 microg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8534468

Group type: EXPERIMENTAL
Intervention: Post‐Anesthetic Discharge Scoring System (PADSS)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Clinical Discharge Criteria
Number of subjects: 247
Study: 2151435

Group type: EXPERIMENTAL
Intervention: Picotamide 300 mg t.i.d. for 10 days
Number of subjects: 10
Study: 6988787

Group type: EXPERIMENTAL
Intervention: Guidance based on the infant's developmental status at each age
Number of subjects: 32

Group type: COMPARATOR
Intervention: Customary care
Number of subjects: 32
Study: 31046117

Group type: EXPERIMENTAL
Intervention: Community-based (CB) recruitment method
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: In-person hospital clinic (HC) recruitment method
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Electronic medical record (EMR) recruitment method
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Information sessions (CB approach)
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Flyers (CB approach)
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Overall recruitment yield
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Cost of recruiting and enrolling one participant
Number of subjects: 453
Study: 30755249

Group type: EXPERIMENTAL
Intervention: PASTA pathway delivered by paramedics including structured pre-hospital information collection, prompted pre-notification, structured handover of information in hospital, and assistance with simple tasks during the initial hospital assessment.
Number of subjects: 1297

Group type: COMPARATOR
Intervention: Standard stroke care according to national and local guidelines for the pre-hospital and hospital assessment of suspected stroke.
Number of subjects: 1297
Study: 28280310

Group type: EXPERIMENTAL
Intervention: Late-to-refill (LTR) reminder calls
Number of subjects: 735218
Study: 25248358

Group type: EXPERIMENTAL
Intervention: Calorie-restriction meal-replacement diet (CRMR)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Calorie-restriction diet with fish oil supplementation (CRF)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Calorie-restriction meal-replacement diet with fish oil supplementation (CRMRF)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Calorie-restriction diet (CR)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 143
Study: 25151418

Group type: EXPERIMENTAL
Intervention: Augmented therapy (parent training, stimulant medication, and risperidone)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Basic therapy (parent training, stimulant medication, and placebo)
Number of subjects: 168
Study: 22376026

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate (CHX) oral swabbing four times/day
Number of subjects: 61

Group type: COMPARATOR
Intervention: Saline oral swabbing four times/day
Number of subjects: 61
Study: 19580706

Group type: EXPERIMENTAL
Intervention: IPC 1 hour/thrice-a-day for 4 months (Group 2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: IPC 2 hours/once-a-day for 4 months (Group 3)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: IPC 1 hour/thrice-a-day for 2 months (Group 4)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: IPC 2 hours/once-a-day for 2 months (Group 5)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No IPC (Group 1)
Number of subjects: 36
Study: 17263604

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave lithotripsy (SWL)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Ureteroscopy (URS)
Number of subjects: 71
Study: 15631278

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (CC) 16 mg plus hydrochlorothiazide (HCTZ) 12.5 mg
Number of subjects: 409

Group type: COMPARATOR
Intervention: Previous monotherapy (PM) plus hydrochlorothiazide (HCTZ) 12.5 mg
Number of subjects: 409
Study: 11603446

Group type: EXPERIMENTAL
Intervention: Magnesium infusion (6 mmol MgSO4 in 100 mL 0.9% NaCl solution, 25 mL/h) administered the day before surgery, just after cardiopulmonary bypass, and once daily for 4 days after surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group received 100 mL 0.9% NaCl solution (25 mL/h) at the same time points
Number of subjects: 200
Study: 9673728

Group type: EXPERIMENTAL
Intervention: Costal cartilage allograft
Number of subjects: 353

Group type: COMPARATOR
Intervention: Bone pate autograft
Number of subjects: 353
Study: 7717809

Group type: EXPERIMENTAL
Intervention: Lactose free formula (AL‐110, Nestle Labs.)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Lactose formula
Number of subjects: 52
Study: 2462660

Group type: EXPERIMENTAL
Intervention: QBC tube test
Number of subjects: 600

Group type: COMPARATOR
Intervention: Thick blood smear
Number of subjects: 600
Study: 4552445

Group type: EXPERIMENTAL
Intervention: Antimicrobials
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 30103740

Group type: EXPERIMENTAL
Intervention: AlphaKit® QuickScreen
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Genotyping (gold standard)
Number of subjects: 1044
Study: 26860430

Group type: EXPERIMENTAL
Intervention: Medium goal (n=19)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Difficult goal (n=19)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Easy goal (n=19)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Do-your-best goal (n=19)
Number of subjects: 96

Group type: COMPARATOR
Intervention: No goal (n=20)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Easy, Medium, and Difficult goal groups
Number of subjects: 96
Study: 24700332

Group type: EXPERIMENTAL
Intervention: Therapeutic Education System (TES)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Therapeutic Education System (TES) among patients with positive urine drug or breath alcohol screen at study entry (N=228)
Number of subjects: 507
Study: 22662395

Group type: EXPERIMENTAL
Intervention: Comparison to a student sample
Number of subjects: 115

Group type: COMPARATOR
Intervention: Comparison to the general population
Number of subjects: 115
Study: 20937428

Group type: EXPERIMENTAL
Intervention: Global postural reeducation (GPR)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Static stretching exercises (SS)
Number of subjects: 24
Study: 18781248

Group type: EXPERIMENTAL
Intervention: First-year alcohol use (abstainer, moderate drinker, heavy drinker)
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Self-efficacy to abstain from alcohol at 15 months
Number of subjects: 952
Study: 16105426

Group type: EXPERIMENTAL
Intervention: Standard therapy + NIPPV (Bi-level positive airway pressure mode)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard therapy only
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: NIPPV
Number of subjects: 36
Study: 12464592

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided excision
Number of subjects: 49

Group type: COMPARATOR
Intervention: Wire-guided excision
Number of subjects: 49
Study: 10069876

Group type: EXPERIMENTAL
Intervention: Formoterol (Foradil), twice daily
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Albuterol, 4 times daily
Number of subjects: 271

Group type: COMPARATOR
Intervention: On-demand albuterol
Number of subjects: 271
Study: 8747036

Group type: COMPARATOR
Intervention: Clomiphene citrate (group II)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clomiphene citrate plus HMG (group III)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spontaneous pregnancy (group I)
Number of subjects: 0
Study: 2074867

Group type: EXPERIMENTAL
Intervention: Nimesulide suppositories
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 7005654

Group type: EXPERIMENTAL
Intervention: Toothpaste based on azulene, sodium chloride and benzalkonium chloride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Toothpaste based on chlorhexidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasonic detartrasis (two initial sessions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detartrasis alone (not followed by regular oral hygiene)
Number of subjects: 0
Study: 30341175

Group type: EXPERIMENTAL
Intervention: Pharmacy intervention (pharmacist visit during second or third chemotherapy infusion)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pharmacy intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 29292344

Group type: EXPERIMENTAL
Intervention: Medial pivot design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single radius design
Number of subjects: 0
Study: 26350034

Group type: EXPERIMENTAL
Intervention: Intervention group receiving: 28,000 IU cholecalciferol/wk for 8 weeks before surgery, 16,000 IU/wk and 1000 mg calcium monocitrate/d after surgery, daily BMI‐adjusted protein supplementation and physical exercise
Number of subjects: 220

Group type: COMPARATOR
Intervention: Non‐intervention group: no preoperative loading, nutritional supplementation, or obligatory physical exercise
Number of subjects: 220
Study: 24674594

Group type: EXPERIMENTAL
Intervention: Integrated training (walking combined with cognitive exercises)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Consecutive training (walking combined with cognitive exercises)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Integrated training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Consecutive training
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Integrated training and Consecutive training
Number of subjects: 120
Study: 22917822

Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride (1 μg/kg per minute after cardiopulmonary bypass or after distal anastomoses)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (not administered landiolol hydrochloride)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride
Number of subjects: 32
Study: 20430451

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal drops (400 microg/day for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (NS) treatment (same duration as intervention)
Number of subjects: 0
Study: 17006442

Group type: EXPERIMENTAL
Intervention: 200 IU Botulinum toxin A (BTX)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 16121634

Group type: EXPERIMENTAL
Intervention: Karyometric measurements from biopsies of rectal mucosa
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Nuclear abnormality values
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Tentative discriminant function (DF I,3)
Number of subjects: 129
Study: 12060188

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 195

Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 195
Study: 10889166

Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg daily for 2 years
Number of subjects: 334

Group type: COMPARATOR
Intervention: Lamivudine for 1 year followed by placebo for 1 year
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: YMDD variant HBV presence
Number of subjects: 334
Study: 9364700

Group type: EXPERIMENTAL
Intervention: Combined DTPa-HBV vaccine
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Extemporaneously mixed DTPa and HBV vaccines
Number of subjects: 3

Group type: COMPARATOR
Intervention: Separate administration of DTPa and HBV vaccines
Number of subjects: 3
Study: 1348515

Group type: EXPERIMENTAL
Intervention: Salbutamol (500 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Formoterol (30 micrograms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2859305

Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Temazepam (30 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31177236

Group type: EXPERIMENTAL
Intervention: Rehabilitation unit equipped with always on naturalistic lighting (IU)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard indoor lighting (CU)
Number of subjects: 90
Study: 29388846

Group type: EXPERIMENTAL
Intervention: Low-dose extract (400 mg/day)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-dose extract (800 mg/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (negative control, only dextran)
Number of subjects: 120
Study: 26190177

Group type: EXPERIMENTAL
Intervention: R-A/L-C (anodal electrode placed over the right SMC and cathodal electrode over the left SMC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-A/R-C (anodal electrode placed over the left SMC and cathodal electrode over the right SMC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 0
Study: 24742019

Group type: EXPERIMENTAL
Intervention: Ethyl-2-cyanoacrylate (ECA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment of each institution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ECA
Number of subjects: 0
Study: 23573201

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg CAF/kg BW)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Coffee (5 mg CAF/kg BW)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Decaffeinated coffee
Number of subjects: 8
Study: 20718214

Group type: EXPERIMENTAL
Intervention: Cast gold partial crowns (CGPCs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Partial ceramic crowns (PCCs)
Number of subjects: 22
Study: 17499955

Group type: EXPERIMENTAL
Intervention: Guideline-concordant clinics
Number of subjects: 256

Group type: COMPARATOR
Intervention: Guideline-discordant clinics
Number of subjects: 256
Study: 16670112

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 40 mg kg(‐1) i.v. as a bolus before induction and 15 mg kg(‐1) h(‐1) by continuous i.v. infusion during the operation
Number of subjects: 60
Study: 14563595

Group type: EXPERIMENTAL
Intervention: Low-dose metoprolol (up to 10 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High-dose metoprolol (up to 20 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 11068993

Group type: EXPERIMENTAL
Intervention: H. pylori eradication treatment (2-week triple therapy: amoxicillin, clarithromycin, omeprazole)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 50
Study: 8684101

Group type: EXPERIMENTAL
Intervention: Co-amoxiclav (375 mg three times daily for 5 days)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 1447587

Group type: EXPERIMENTAL
Intervention: Various approaches for preparing adults for cardiac catheterization
Number of subjects: 0